← Leaderboards
Isabel Scholz
Nanotherapeutics, Inc.
$799,780
Attributed
$799,780
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $485.3K · FY2023–24$500K$375K$250K$125K$0
'23
'24
Funding mix
By agency
NIH$799,780 · 1
By mechanism
N01$799,780 · 1
Top collaborators
No co-investigators on record.
Most similar at Nanotherapeutics, Inc.
Same institution · by research overlap
- Yawei Ni$3,837,115
- Milan Tomic$15,158,708
- James Forrest Kirk$1,785,738
- James David Talton$15,179,333
- Robert House$3,149,878
Others in their field
Other Rising Stars on “Vector”
- Venkata Mangalampalli · Leidos Biomedical Research, Inc.$11,756,555
- Amanda Burnaugh · Battelle Centers/Pub Hlth Res & Evaluatn$9,197,577
- Nancy Jean Sullivan · Boston University Medical Campus$7,541,758
- Luis A Cifuentes · New Mexico State University Las Cruces$7,084,640
- Nicolas Collins · Vaccine Formulation Institute (Ch) Ltd$6,937,118
- Eva A Siegmann · Suny At Stony Brook$4,390,221
Research focus
VectorAssay DevelopmentAttenuatedBiological ProductsBiotechnologyDevelopment PlansDocumentationEvaluationFormulationTherapeutic DevelopmentAnalytical MethodInfluenza TherapeuticManufactureMonoclonal AntibodiesNucleic AcidsPeptidesPlasmidsPreclinical DevelopmentProduct DevelopmentRecombinant ProteinsService ProgramsServicesSmall Interfering RnaInfectious Diseases Research